Risk factor
Very poor trading liquidity
Profitability factor
Strong growth
About
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy livingbrain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r
Target Price
The average target price of CLV.AX is 0.87 and suggests 13% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell